BiomX PHGE
NYSE PHGE
$0.14 0.00 (-1.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

BiomX (PHGE) Other Non Operating Income (2022 - 2026)

BiomX (PHGE) posted Other Non Operating Income of -$377000.0 for Q1 2026, down 141.25% sequentially from $914000.0 in Q1 2025, and down 141.25% YoY from $914000.0 in Q1 2025.

BiomX (PHGE) Other Non Operating Income (2022 - 2026) Analysis & Trends

BiomX has reported Other Non Operating Income for 4 years, with the latest figure at -$377000.0 in Q1 2026.

  • Quarterly Other Non Operating Income fell 141.25% year-over-year to -$377000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 38.24% YoY) and the FY2025 annual result came in at -$481000.0, down 2572.22% from the prior year.
  • Other Non Operating Income slipped to -$377000.0 in Q1 2026 per PHGE's latest filing, from $914000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $914000.0 in Q1 2025 and troughed at -$377000.0 in Q1 2026.
  • A 4-year average of $268800.0 and a median of $302500.0 in 2022 frame the typical range for Other Non Operating Income.
  • The sharpest annual moves came in 2023 and 2026: Other Non Operating Income soared 275.86% in 2023, then sank 141.25% in 2026.
  • Over 4 years, Other Non Operating Income stood at $196000.0 in 2022, then rose by 9.69% to $215000.0 in 2023, then jumped by 325.12% to $914000.0 in 2025, then tumbled by 141.25% to -$377000.0 in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered -$377000.0, $914000.0, and $215000.0 for Q1 2026, Q1 2025, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 BiomX 351,774.34 -816,225.66 -

Historic Data

Download Data
DateValue
Mar 31, 2026 -377,000.00
Mar 31, 2025 914,000.00
Dec 31, 2023 215,000.00
Sep 30, 2023 382,000.00
Jun 30, 2023 325,000.00
Mar 31, 2023 327,000.00
Dec 31, 2022 196,000.00
Sep 30, 2022 280,000.00
Jun 30, 2022 339,000.00
Mar 31, 2022 87,000.00